These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo. Perwitasari O; Johnson S; Yan X; Howerth E; Shacham S; Landesman Y; Baloglu E; McCauley D; Tamir S; Tompkins SM; Tripp RA J Virol; 2014 Sep; 88(17):10228-43. PubMed ID: 24965445 [TBL] [Abstract][Full Text] [Related]
3. Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses. Pickens JA; Tripp RA Viruses; 2018 Jan; 10(1):. PubMed ID: 29361733 [TBL] [Abstract][Full Text] [Related]
5. KPT-330 inhibitor of XPO1-mediated nuclear export has anti-proliferative activity in hepatocellular carcinoma. Zheng Y; Gery S; Sun H; Shacham S; Kauffman M; Koeffler HP Cancer Chemother Pharmacol; 2014 Sep; 74(3):487-95. PubMed ID: 25030088 [TBL] [Abstract][Full Text] [Related]
6. Anti-tumor activity of selective inhibitor of nuclear export (SINE) compounds, is enhanced in non-Hodgkin lymphoma through combination with mTOR inhibitor and dexamethasone. Muqbil I; Aboukameel A; Elloul S; Carlson R; Senapedis W; Baloglu E; Kauffman M; Shacham S; Bhutani D; Zonder J; Azmi AS; Mohammad RM Cancer Lett; 2016 Dec; 383(2):309-317. PubMed ID: 27693556 [TBL] [Abstract][Full Text] [Related]
7. XPO1/CRM1 is a promising prognostic indicator for neuroblastoma and represented a therapeutic target by selective inhibitor verdinexor. Pan L; Cheng C; Duan P; Chen K; Wu Y; Wu Z J Exp Clin Cancer Res; 2021 Aug; 40(1):255. PubMed ID: 34384466 [TBL] [Abstract][Full Text] [Related]
8. Biologic activity of the novel orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 against canine melanoma cell lines. Breit MN; Kisseberth WC; Bear MD; Landesman Y; Kashyap T; McCauley D; Kauffman MG; Shacham S; London CA BMC Vet Res; 2014 Jul; 10():160. PubMed ID: 25022346 [TBL] [Abstract][Full Text] [Related]
9. The respiratory syncytial virus matrix protein possesses a Crm1-mediated nuclear export mechanism. Ghildyal R; Ho A; Dias M; Soegiyono L; Bardin PG; Tran KC; Teng MN; Jans DA J Virol; 2009 Jun; 83(11):5353-62. PubMed ID: 19297465 [TBL] [Abstract][Full Text] [Related]
10. Selective Inhibitor of Nuclear Export (SINE) Compounds Alter New World Alphavirus Capsid Localization and Reduce Viral Replication in Mammalian Cells. Lundberg L; Pinkham C; de la Fuente C; Brahms A; Shafagati N; Wagstaff KM; Jans DA; Tamir S; Kehn-Hall K PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005122. PubMed ID: 27902702 [TBL] [Abstract][Full Text] [Related]
11. Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo. Kashyap T; Murray J; Walker CJ; Chang H; Tamir S; Hou B; Shacham S; Kauffman MG; Tripp RA; Landesman Y Antiviral Res; 2021 Aug; 192():105115. PubMed ID: 34157321 [TBL] [Abstract][Full Text] [Related]
12. Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276. Schmidt J; Braggio E; Kortuem KM; Egan JB; Zhu YX; Xin CS; Tiedemann RE; Palmer SE; Garbitt VM; McCauley D; Kauffman M; Shacham S; Chesi M; Bergsagel PL; Stewart AK Leukemia; 2013 Dec; 27(12):2357-65. PubMed ID: 23752175 [TBL] [Abstract][Full Text] [Related]
13. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses. Ohol YM; Wang Z; Kemble G; Duke G PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560 [TBL] [Abstract][Full Text] [Related]
14. Nucleo-cytoplasmic transport as a therapeutic target of cancer. Gravina GL; Senapedis W; McCauley D; Baloglu E; Shacham S; Festuccia C J Hematol Oncol; 2014 Dec; 7():85. PubMed ID: 25476752 [TBL] [Abstract][Full Text] [Related]
15. A method for quantification of exportin-1 (XPO1) occupancy by Selective Inhibitor of Nuclear Export (SINE) compounds. Crochiere ML; Baloglu E; Klebanov B; Donovan S; Del Alamo D; Lee M; Kauffman M; Shacham S; Landesman Y Oncotarget; 2016 Jan; 7(2):1863-77. PubMed ID: 26654943 [TBL] [Abstract][Full Text] [Related]
16. Verdinexor, a Selective Inhibitor of Nuclear Exportin 1, Inhibits the Proliferation and Migration of Esophageal Cancer via XPO1/c-Myc/FOSL1 Axis. Ou L; Wang X; Cheng S; Zhang M; Cui R; Hu C; Liu S; Tang Q; Peng Y; Chai R; Xie S; Wang S; Huang W; Wang X Int J Biol Sci; 2022; 18(1):276-291. PubMed ID: 34975332 [TBL] [Abstract][Full Text] [Related]
17. Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin. De Cesare M; Cominetti D; Doldi V; Lopergolo A; Deraco M; Gandellini P; Friedlander S; Landesman Y; Kauffman MG; Shacham S; Pennati M; Zaffaroni N Oncotarget; 2015 May; 6(15):13119-32. PubMed ID: 25948791 [TBL] [Abstract][Full Text] [Related]